Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 1701637, 8 pages
http://dx.doi.org/10.1155/2016/1701637
Research Article

Overexpression of Prolyl-4-Hydroxylase-α1 Stabilizes but Increases Shear Stress-Induced Atherosclerotic Plaque in Apolipoprotein E-Deficient Mice

Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Department of Cardiology, Qilu Hospital of Shandong University, Ji’nan 250012, China

Received 29 May 2016; Revised 19 September 2016; Accepted 22 September 2016

Academic Editor: Michele Malaguarnera

Copyright © 2016 Xiao-qing Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Virmani, A. P. Burke, A. Farb, and F. D. Kolodgie, “Pathology of the vulnerable plaque,” Journal of the American College of Cardiology, vol. 47, no. 8, pp. C13–C18, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Virmani, A. P. Burke, F. D. Kolodgie, and A. Farb, “Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque,” Journal of Interventional Cardiology, vol. 16, no. 3, pp. 267–272, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Ylä-Herttuala, J. F. Bentzon, M. Daemen et al., “Stabilization of atherosclerotic plaques: an update,” European Heart Journal, vol. 34, no. 42, pp. 3251–3258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. A. V. Finn, M. Nakano, J. Narula, F. D. Kolodgie, and R. Virmani, “Concept of vulnerable/unstable plaque,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 7, pp. 1282–1292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Libby, “Molecular bases of the acute coronary syndromes,” Circulation, vol. 91, no. 11, pp. 2844–2850, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. C. G. Santos-Gallego, B. Picatoste, and J. J. Badimón, “Pathophysiology of acute coronary syndrome,” Current Atherosclerosis Reports, vol. 16, no. 4, article 401, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Ichii, H. Koyama, S. Tanaka et al., “Fibrillar collagen specifically regulates human vascular smooth muscle cell genes involved in cellular responses and the pericellular matrix environment,” Circulation Research, vol. 88, no. 5, pp. 460–467, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Koyama, E. W. Raines, K. E. Bornfeldt, J. M. Roberts, and R. Ross, “Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors,” Cell, vol. 87, no. 6, pp. 1069–1078, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. K. I. Kivirikko, T. Helaakoski, K. Tasanen et al., “Molecular biology of prolyl 4-hydroxylase,” Annals of the New York Academy of Sciences, vol. 580, pp. 132–142, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Annunen, H. Autio-Harmainen, and K. I. Kivirikko, “The novel type II prolyl 4-hydroxylase is the main enzyme form in chondrocytes and capillary endothelial cells, whereas the type I enzyme predominates in most cells,” The Journal of Biological Chemistry, vol. 273, no. 11, pp. 5989–5992, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Z. Huang, X. X. Liu, J. T. Song et al., “Prolyl-4-hydroxylase-α1 improves the stability of advanced plaques but accelerates the atherosclerotic lesion formation of early plaques,” European Heart Journal, Supplement, vol. 17, pp. C49–C58, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Zhang, X.-Z. Huang, X.-N. Li et al., “Interleukin 6 destabilizes atherosclerotic plaques by downregulating prolyl-4-hydroxylase α1 via a mitogen-activated protein kinase and c-Jun pathway,” Archives of Biochemistry and Biophysics, vol. 528, no. 2, pp. 127–133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Li, X.-J. Cai, M. Feng, Y.-Y. Rong, Y. Zhang, and M. Zhang, “Effect of adiponectin overexpression on stability of preexisting plaques by inducing prolyl-4-hydroxylase expression,” Circulation Journal, vol. 74, no. 3, pp. 552–559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Cheng, D. Tempel, R. van Haperen et al., “Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress,” Circulation, vol. 113, no. 23, pp. 2744–2753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Adiguzel, P. J. Ahmad, C. Franco, and M. P. Bendeck, “Collagens in the progression and complications of atherosclerosis,” Vascular Medicine, vol. 14, no. 1, pp. 73–89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. E. P. Amento, N. Ehsani, H. Palmer, and P. Libby, “Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 11, no. 5, pp. 1223–1230, 1991. View at Publisher · View at Google Scholar · View at Scopus
  17. J. G. de Tena, I. Kriszbacher, M. Koppán, J. Bódis, and G. K. Hansson, “Inflammation, atherosclerosis, and coronary artery disease,” The New England Journal of Medicine, vol. 353, no. 4, pp. 429–430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. B. Wesley II, X. P. Meng, D. Godin, and Z. S. Galis, “Extracellular matrix modulates macrophage functions characteristic to atheroma—collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 3, pp. 432–440, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. K. J. Moore and I. Tabas, “Macrophages in the pathogenesis of atherosclerosis,” Cell, vol. 145, no. 3, pp. 341–355, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. K. J. Moore, F. J. Sheedy, and E. A. Fisher, “Macrophages in atherosclerosis: a dynamic balance,” Nature Reviews Immunology, vol. 13, no. 10, pp. 709–721, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. T. A. Seimon, Y. Wang, S. Han et al., “Macrophage deficiency of p38α MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice,” The Journal of Clinical Investigation, vol. 119, no. 4, pp. 886–898, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Van Den Diepstraten, K. Papay, Z. Bolender, A. Brown, and J. G. Pickering, “Cloning of a novel prolyl 4-hydroxylase subunit expressed in the fibrous cap of human atherosclerotic plaque,” Circulation, vol. 108, no. 5, pp. 508–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Zhang, X. Meng, J. Kong et al., “Simvastatin increases prolyl-4-Hydroxylase α1 expression in atherosclerotic plaque and ox-LDL-stimulated human aortic smooth muscle cells via p38 MAPK and ERK1/2 signaling,” Journal of Molecular and Cellular Cardiology, vol. 65, pp. 43–50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. Ambrose and E. E. Martinez, “A new paradigm for plaque stabilization,” Circulation, vol. 105, no. 16, pp. 2000–2004, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Naghavi, P. Libby, E. Falk et al., “From vulnerable plaque to vulnerable patient—a call for new definitions and risk assessment strategies: part I,” Circulation, vol. 108, no. 14, pp. 1664–1672, 2003. View at Publisher · View at Google Scholar
  26. J. J. Boyle, “Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture,” Current Vascular Pharmacology, vol. 3, no. 1, pp. 63–68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. G. K. Hansson, “Inflammation, atherosclerosis, and coronary artery disease,” The New England Journal of Medicine, vol. 352, no. 16, pp. 1685–1695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. F. D. Kolodgie, J. Narula, A. P. Burke et al., “Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death,” The American Journal of Pathology, vol. 157, no. 4, pp. 1259–1268, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Redondo, C. G. Santos-Gallego, P. Ganado et al., “Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-β,” Circulation, vol. 107, no. 4, pp. 626–629, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Redondo, C. G. Santos-Gallego, and T. Tejerina, “TGF-β1: a novel target for cardiovascular pharmacology,” Cytokine & Growth Factor Reviews, vol. 18, no. 3-4, pp. 279–286, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Redondo, E. Ruiz, C. G. Santos-Gallego, E. Padilla, and T. Tejerina, “Pioglitazone induces vascular smooth muscle cell apoptosis through a peroxisome proliferator-activated receptor-γ, transforming growth factor-β1, and a Smad2-dependent mechanism,” Diabetes, vol. 54, no. 3, pp. 811–817, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. M. W. Majesky, V. Lindner, D. R. Twardzik, S. M. Schwartz, and M. A. Reidy, “Production of transforming growth factor β1 during repair of arterial injury,” The Journal of Clinical Investigation, vol. 88, no. 3, pp. 904–910, 1991. View at Publisher · View at Google Scholar · View at Scopus
  33. P. J. Little, L. Tannock, K. L. Olin, A. Chait, and T. N. Wight, “Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-β1 exhibit increased binding to LDLs,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 1, pp. 55–60, 2002. View at Publisher · View at Google Scholar · View at Scopus